Divestitures made during a previous healthcare insurance merger did little to maintain competition among Medicare Advantage plans, reaffirming concerns that the Aetna-Humana merger will increase premiums for seniors and lead to higher costs within the Medicare program, according to a new report from the Centers for American Progress.
As regulators continue to review the Aetna-Humana and Anthem-Cigna mergers, two new blog posts from Health Affairs call into question the companies' justification for the mega-deals.
Two major insurance mergers are gradually gaining approval from state regulators, though the final approval of the mergers still depends on what could be a more demanding federal review.
Both Aetna and Humana shareholders "overwhelmingly" approved the two insurance giants' proposed merger in separate meetings Monday--but the deal still faces hurdles in the regulatory review process.
The health insurance industry may have reached a tipping point that goes much deeper than the proposed mergers between four large insurers, Paul Keckley, managing director for the Navigant Center for Healthcare Research and Policy Analysis, writes in a recent blog post.
Though divestitures are common in large-scale acquisitions, Anthem does not expect to have to make any as it closes its merger with Cigna, according to a newly released piece from Policy and Regulatory Report.
During the third of three recent hearings on consolidation in the healthcare industry, representatives from the provider community made it clear that they are not going to let the pending health insurer mergers go down without a fight.
When it comes to the rigorous review process that major industry mergers must face, how soon is too soon to declare victory? Personally, I would argue that any time before the Department of Justice...
During Tuesday's Senate committee hearing on the two pending health insurer mergers, the CEOs of Aetna and Anthem, as expected, explained why they thought the deals' benefits outweigh any anticompetitive concerns. But as Sen. Richard Blumenthal (D-Conn.), noted, the two-plus hour hearing only scratched the surface of some of the complex issues associated with the proposed deals, which would pare down the country's largest health insurers from five to three.
Senators and expert witnesses alike expressed skepticism about the proposed merger deals between four of the country's largest health insurers during a hearing Tuesday on Capitol Hill.